Article Per Year (5 Year)
p-Index From 2020 - 2025
0.702
P-Index
This Author published in this journals
All Journal Jurnal Sains Teknologi dan Lingkungan (JSTL) Jurnal Biologi Tropis Jurnal Kesehatan Tambusai
Pratiwi, Rukmanggana Satya
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Computer Science & IT Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
Terapi Saat Ini untuk Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Sebuah Literature Review Hunaifi, Ilsa Hunaifi; Wicaksono, Teguh Budi; Nugraha, Gede Rama Hardy; Maulida, Rizka Ayu; Kusumadewi, Rima Cahyati; Pratiwi, Rukmanggana Satya; Amaliya, Annisa Risqi; Sepestian, Ghina Shadrina Rienti
JURNAL SAINS TEKNOLOGI & LINGKUNGAN Vol. 10 No. 3 (2024): JURNAL SAINS TEKNOLOGI & LINGKUNGAN
Publisher : LPPM Universitas Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jstl.v10i3.619

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease. The European Academy of Neurology recommends treatment using corticosteroids, immunoglobulin, plasma exchange, & other treatments as treatment options for chronic inflammatory demyelinating polyradiculoneuropathy. However, several studies in recent years have shown that there is potential in the treatment of chronic inflammatory demyelinating Polyradiculoneuropathy. The aim of this literature review is to provide the latest therapy for chronic inflammatory demyelinating polyradiculoneuropathy based on guidelines as well as other information therapy alternatives. The method used in this literature review uses searches in several databases. The results of several studies show the development of chronic inflammatory demyelinating polyradiculoneuropathy therapy both pharmacologically & non-pharmacologically. The development of therapy for chronic inflammatory demyelinating polyradiculoneuropathy, namely hematopoietic stem cells & spinal cord stimulation, shows potential as a therapeutic option for patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Current Therapies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Literature Review Wicaksono, Teguh Budi; Nugraha, Gede Rama Hardy; Maulida, Rizka Ayu; Kusumadewi, Rima Cahyati; Pratiwi, Rukmanggana Satya; Amaliya, Annisa Risqi; Sepestian, Ghina Shadrina Rienti; Hunaifi, Ilsa
Jurnal Biologi Tropis Vol. 24 No. 3 (2024): July - September
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v24i3.7395

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease. The European Academy of Neurology recommends treatment using corticosteroids, immunoglobulin, plasma exchange, & other treatments as treatment options for chronic inflammatory demyelinating polyradiculoneuropathy. However, several studies in recent years have shown that there is potential in the treatment of chronic inflammatory demyelinating Polyradiculoneuropathy. The aim of this literature review is to provide the latest therapy for chronic inflammatory demyelinating polyradiculoneuropathy based on guidelines as well as other information therapy alternatives. The method used in this literature review uses searches in several databases. The results of several studies show the development of chronic inflammatory demyelinating polyradiculoneuropathy therapy both pharmacologically & non-pharmacologically. The development of therapy for chronic inflammatory demyelinating polyradiculoneuropathy, namely hematopoietic stem cells & spinal cord stimulation, shows potential as a therapeutic option for patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Pathophysiology of Rabies Encephalitis and Treatment of Rabies : A Literature Review Ginuluh, Gintis Dhimar; Kamila, Alya Syafa; Humam, Anang Muh Naufal; Helmiana, Putri Fatimah; Pratiwi, Rukmanggana Satya; Hunaifi, Ilsa; Arsy, Lazuardi
Jurnal Biologi Tropis Vol. 24 No. 1b (2024): Special Issue
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v24i1b.7951

Abstract

Rabies is a zoonotic disease transmitted by the saliva of mammals infected with Rabies lyssavirus. Rabies is a lethal disease that is still a health problem in Indonesia. This article aims to review the clinical features, diagnosis, pathophysiology, and management of rabies. This research collects and analyzes literature related to rabies that was conducted through Google Scholar, Pubmed, and ScienceDirect. The review results show that rabies with clinical features, especially rabies encephalitis had poor outcomes. Rabies is a neurotropic virus that spreads through neurons and attack CNS causing rabies encephalitis. The management is categorized into pre-exposure treatment, post-exposure treatment, and palliative treatment. An understandable information regarding the mechanism of rabies encephalitis and rabies management is very important to minimize deaths caused by rabies.
CHRONIC MYELOID LEUKEMIA Akbar, Nugraha Malik; Pratiwi, Rukmanggana Satya; Azmi, Naurah Arika; Supriantarini, Dita; Amatullah, Tazkiyah Arafah; Anggoro, Joko
Jurnal Kesehatan Tambusai Vol. 5 No. 4 (2024): DESEMBER 2024
Publisher : Universitas Pahlawan Tuanku Tambusai

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31004/jkt.v5i4.38268

Abstract

Chronic Myelogenous Leukemia  (CML) merupakan suatu jenis kanker yang disebabkan oleh gangguan pada hematopoietic stem cell. CML adalah bentuk leukemia yang ditandai dengan peningkatan dan pertumbuhan yang tak terkendali dari sel myeloid pada sumsum tulang. CML merupakan gangguan stem sel sumsum tulang klonal, dimana ditemukan proliferasi dari granulosit matang (neutrofil, eosinofil, dan basofil) dan prekursor nya.Metode yang digunakan dalam penulisan tinjauan pustaka ini adalah studi literatur dari berbagai referensi. Pencarian literatur ini menggunakan basis data online yaitu, PubMed, Google Scholar, ProQuest dan Mendeley Search. CML pada umumnya lebih cenderung terjadi pada usia 53-60 tahun, namun usia rata-rata dianggap sebagai usia 40 tahun, walaupun dapat ditemukan pada usia muda dan biasanya lebih progresif. Penyebab dari CML adalah tidak jelas dengan peran penting dari faktor genetic dan lingkungan, seperti paparan terhadap radiasi dan sebagainya. Dalam perjalanan penyakitnya, CML dapat dibagi kepada biphasic dan triphasic course. Proses awalnya adalah kronik dan berlanjut ke fase blastik terminal. Leukemia mielositik kronik dibagi menjadi 3 fase, yaitu: fase kronik, fase akselerasi, dan fase krisis blast. Terapi yang digunakan dalam tatalaksana CML busulfan, Hidroxiurea, Imatinib (Gleevec), nilotinib (Tasigna), dasatinib (Sprycel), Interferon, Transplantasi sumsum tulang alogenik (stem cell transplantation, SCT).CML yang tidak diobati dan berlangsung lama akan menimbulkan komplikasi berupa hepatomegali, splenomegali, anemia yang memburuk.
Co-Authors Akbar, Nugraha Malik Amaliya, Annisa Risqi Amatullah, Tazkiyah Arafah Anggoro, Joko Azmi, Naurah Arika Ginuluh, Gintis Dhimar Helmiana, Putri Fatimah Humam, Anang Muh Naufal Hunaifi, Ilsa Hunaifi Ilsa Hunaifi, Ilsa Kamila, Alya Syafa Kusumadewi, Rima Cahyati Lazuardi Arsy, Lazuardi Maulida, Rizka Ayu Nugraha, Gede Rama Hardy Sepestian, Ghina Shadrina Rienti Supriantarini, Dita Teguh Budi Wicaksono